Search
PEI Biosimilar Initiative
Some drugs are made using living organisms or their cells. These drugs are called biologics. The first version of a biologic drug to be produced is called the originator or reference biologic. Biosimilars are highly similar versions of originator biologic drugs. They are produced when the patent expires on the originator biologic drug. Biosimilars are less expensive drugs that are reviewed by Health Canada to ensure they work in the same way as the originator biologic drugs and are equally effective. Through the PEI Biosimilar Initiative, coverage under PEI Pharmacare for certain biologic...
Catastrophic Drug Program
If the cost of your prescription medication is making it hard for you to pay other essential life expenses, you may qualify for coverage of certain medications through the Catastrophic Drug Program. Am I eligible? You and members of your household are eligible for the program if...
DPP-4 / SGLT2 Inhibitors Special Authorization Request Form
Special authorization request form to be completed by your physician or diagnosing specialist.
Standard Special Authorization Request Form
Some medications in the PEI Pharmacare Formulary are approved on a special authorization basis only. If your physician prescribes a drug in this category, you can submit a Standard Special Authorization Request form to have a medication considered for coverage.
Ambulance Response Times
What is a response time? An ambulance response time is defined as the time from when the 9-1-1 call is received at the Public Safety Answering Point (9-1-1 Dispatch Centre) until the arrival of the first paramedic on scene. How are response times reported? Ambulance response...